SOMERVILLE, Mass., September 27, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the filing of its Form 10-Q for the quarter ended June 30, 2024 (the "Q2 2024 Form 10-Q") ...
Bluebird bio will lay off about 25% of its workforce, or 95 employees, the gene therapy maker said on Tuesday, in a second major restructuring in two years as the company focuses on launching its ...
On Thursday, bluebird bio Inc (BLUE) stock saw a modest uptick, ending the day at $0.5 which represents a slight increase of $0.02 or 4.17% from the prior close of $0.48. The stock opened at $0.51 and ...